Molecular Imaging Insight - September 2007 - (Page 12) ADDITIONAL RESOURCES: Survival Tips: What To Do About the DRA By MARy C. TIERNE y SnM rounDTABlE Expert Panel Defines State of the Art and Future of Molecular Imaging M 1 Molecular Imaging Insight olecular imaging is a quickly evolving field in which clinical practice and clinical studies are steadily proving its merits in better patient management and outcomes. It is having a large impact on clinical practice in the diagnosis and staging of cancer, diagnosis, evaluating heart and neurological diseases, and beginning to help in infection imaging, particularly to diagnose fevers of unknown origin. What’s fueling all this? Innovation. Innovation and its translation into clinical practice within molecular imaging was topic of a roundtable discussion attended by about 500 people in Washington, D.C., that coincided with the Society of Nuclear Medicine meeting in June. The event was sponsored by Siemens Medical Solutions. The discussion focused on four areas: personalized medicine, clinical adoption of molecular imaging technologies, biomarker research and the Deficit Reduction Act (DRA). The expert panel included Manuel Cerquiera MD, chairman of nuclear medicine and professor of radiology and medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; Professor Torsten Kuwert, MD, Chairman of the Department of Nuclear Medicine, University of Erlangen-Nuremberg, Germany; Rodney J. Hicks, MD, FRACP, Professor, Department of Medicine, the University of Melbourne, Director, Centre for Molecular Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia; Douglas Hadley, MD, medical officer and director of Cigna’s coverage policy unit; Tim Trysla, counsel of the healthcare group at Alston and Berg and executive director of the Access to Medicare Imaging Coalition. He also serves as chief of staff to the Centers for Medicaid and Medicare; Michael Reitermann, president of Siemens Medical Solutions Molecular Imaging Division; and Ron Petrocelli, MD, chief medical officer of Siemens Medical Solutions Molecular Imaging Division. September 2007 https://www.mi-lifenet.com/miudemo/features/toolkits/dra/
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.